Medicare (CMS) December 23rd 2018 Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

December 23rd 2018 Medicare (CMS) LCD Updates:

• L36402             Allergy Testing
• A56065            Billing and Coding Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3
• A56232            Billing and Coding Guidelines for Foot Care
• A52371            Bortezomib – Related to LCD L33394
• L33950             Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
• L33585             Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography
• A52849            Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography – Supplemental Instructions Article
• L35490             Category III Codes
• L33392             Category III CPT® Codes
• A56195            Category III CPT® Codes- Related to Category III CPT® Codes (L33392)
• A52953            Chemotherapy Administration
• A52991            Chemotherapy Administration
• A55639            Chemotherapy Agents for Non-Oncologic Conditions
• L34093             Chemotherapy and Biologicals
• A55703            Coding for Hemodialysis Sessions
• A53052            Coding Guidelines for Home Health Speech-Language Pathology
• A55052            Coding Radiopharmaceutical Agents
• A54176            Drug Administration Coding
• A54848            Drug Administration Coding
• A54848            Drug Administration Coding
• L37379             Echocardiography
• L34633             Erythropoiesis Stimulating Agents (ESAs)
• L37709             Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
• L36404             Foot Care
• L34563             Home Health Speech-Language Pathology
• L34699             Human Granulocyte/Macrophage Colony Stimulating Factors
• A52420            Hyaluronans Intra-articular Injections of – Related to LCD L33394
• L34771             Immune Globulins
• A54953            Independent Diagnostic Testing Facilities- physician supervision and technician requirements
• L35677             Infliximab
• L34623             Intraoperative Neurophysiological Testing
• L35724             Lab: Controlled Substance Monitoring and Drugs of Abuse Testing
• A52842            Local Coverage Determination (LCD) Reconsideration Process – Medical Policy Article
• A52453            Luteinizing Hormone-Releasing Hormone (LHRH) Analogs – Related to LCD L33394
• L34373 (retired)        Magnetic Resonance Imaging (MRI) of Any Joint of the Lower Extremities
• A54767            Medicare Preventive Coverage for Certain Vaccines
• L35494             Mohs Micrographic Surgery
• L37224             MolDX: APC and MUTYH Gene Testing
• A55141            MolDX: ApoE Genotype Coding and Billing Guidelines
• A53605            MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing Coding and Billing Guidelines
• A54685            MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing Coding and Billing Guidelines
• A53602            MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing Coding and Billing Guidelines
• A54253            MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing Coding and Billing Guidelines
• A53550            MolDX: ATP7B Gene Tests Coding and Billing Guidelines
• A54254            MolDX: ATP7B Gene Tests Coding and Billing Guidelines
• A53600            MolDX: BCKDHB Gene Test Coding and Billing Guidelines
• A54255            MolDX: BCKDHB Gene Test Coding and Billing Guidelines
• A53531            MolDX: BCR-ABL Coding and Billing Guidelines
• A54686            MolDX: BCR-ABL Coding and Billing Guidelines
• L37216             MolDX: BDX-XL2
• A55135            MolDX: Billing and Coding for Lynch Syndrome Testing Services
• A53540            MolDX: BLM Gene Analysis Coding and Billing Guidelines
• A54256            MolDX: BLM Gene Analysis Coding and Billing Guidelines
• L36082             MolDX: BRCA1 and BRCA2 Genetic Testing
• L36456             MolDX: BRCA1 and BRCA2 Genetic Testing
• L36813             MolDX: BRCA1 and BRCA2 Genetic Testing
• L36813             MolDX: BRCA1 and BRCA2 Genetic Testing
• L35631             MolDX: Breast Cancer Index℠ Genetic Assay
• L36314             MolDX: Breast Cancer Index℠ Genetic Assay
• L36458             MolDX: Breast Cancer Index℠ Genetic Assay
• L36316             MolDX: Breast Cancer Index?; Genetic Assay
• A55117            MolDX: CFTR Gene Analysis Billing and Coding Guidelines
• A55118            MolDX: CFTR Gene Analysis Billing and Coding Guidelines
• A53615            MolDX: CFTR Gene Analysis Coding and Billing Guidelines
• A54258            MolDX: CFTR Gene Analysis Coding and Billing Guidelines
• A55157            MolDX: CHD7 Gene Analysis Coding and Billing Guidelines
• L35072             MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• L35332             MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• L36310             MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• L36312             MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• L36398             MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
• A55181            MolDX: ENG and ACVRL1 Gene Tests Billing and Coding Guidelines
• A55182            MolDX: ENG and ACVRL1 Gene Tests Billing and Coding Guidelines
• A53536            MolDX: ENG and ACVRL1 Gene Tests Coding and Billing Guidelines
• A54262            MolDX: ENG and ACVRL1 Gene Tests Coding and Billing Guidelines
• A55159            MolDX: ENG and ACVRL1 Gene Tests Coding and Billing Guidelines
• A55183            MolDX: FANCC Genetic Testing Billing and Coding Guidelines
• A55184            MolDX: FANCC Genetic Testing Billing and Coding Guidelines
• A53628            MolDX: FANCC Genetic Testing Coding and Billing Guidelines
• A54263            MolDX: FANCC Genetic Testing Coding and Billing Guidelines
• L37350             MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)
• L37368             MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)
• L37766             MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)
• A55241            MolDX: Fragile X Billing and Coding Guidelines
• A55242            MolDX: Fragile X Billing and Coding Guidelines
• A53638            MolDX: Fragile X Coding and Billing Guidelines Update
• A54264            MolDX: Fragile X Coding and Billing Guidelines Update
• A55163            MolDX: Fragile X Coding and Billing Guidelines Update
• L36815             MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
• L36400             MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
• L36793             MolDX: Genetic Testing for Lynch Syndrome
• A55253            MolDX: HBB Gene Tests Billing and Coding Guidelines
• A55254            MolDX: HBB Gene Tests Billing and Coding Guidelines
• A53493            MolDX: HBB Gene Tests Coding and Billing Guidelines
• A54267            MolDX: HBB Gene Tests Coding and Billing Guidelines
• A55255            MolDX: HEXA Gene Analysis Billing and Coding Guidelines
• A55256            MolDX: HEXA Gene Analysis Billing and Coding Guidelines
• A53598            MolDX: HEXA Gene Analysis Coding and Billing Guidelines
• A54268            MolDX: HEXA Gene Analysis Coding and Billing Guidelines
• A55612            MolDX: IKBKAP Genetic Testing Billing and Coding Guidelines
• A55613            MolDX: IKBKAP Genetic Testing Billing and Coding Guidelines
• A53596            MolDX: IKBKAP Genetic Testing Coding and Billing Guidelines
• A54270            MolDX: IKBKAP Genetic Testing Coding and Billing Guidelines
• A55277            MolDX: L1CAM Gene Sequencing Billing and Coding Guidelines
• A55278            MolDX: L1CAM Gene Sequencing Billing and Coding Guidelines
• A53659            MolDX: L1CAM Gene Sequencing Coding and Billing Guidelines
• A54274            MolDX: L1CAM Gene Sequencing Coding and Billing Guidelines
• A55192            MolDX: L1CAM Gene Sequencing Coding and Billing Guidelines
• A55283            MolDX: MCOLN1 Genetic Testing Billing and Coding Guidelines
• A55284            MolDX: MCOLN1 Genetic Testing Billing and Coding Guidelines
• A53630            MolDX: MCOLN1 Genetic Testing Coding and Billing Guidelines
• A54277            MolDX: MCOLN1 Genetic Testing Coding and Billing Guidelines
• A55285            MolDX: MECP2 Genetic Testing Billing and Coding Guidelines
• A55286            MolDX: MECP2 Genetic Testing Billing and Coding Guidelines
• A53574            MolDX: MECP2 Genetic Testing Coding and Billing Guidelines
• A54278            MolDX: MECP2 Genetic Testing Coding and Billing Guidelines
• L35974             MolDX: MGMT Promoter Methylation Analysis
• L37001             MolDX: MGMT Promoter Methylation Analysis
• A55191            MolDX: MMACHC Test Coding and Billing Guidelines
• L35025             MolDX: Molecular Diagnostic Tests (MDT)
• L35025             MolDX: Molecular Diagnostic Tests (MDT)
• L35160             MolDX: Molecular Diagnostic Tests (MDT)
• L35160             MolDX: Molecular Diagnostic Tests (MDT)
• L36256             MolDX: Molecular Diagnostic Tests (MDT)
• L36256             MolDX: Molecular Diagnostic Tests (MDT)
• L36807             MolDX: Molecular Diagnostic Tests (MDT)
• A54338            MolDX: Myriad’s BRACAnalysis CDx™ Coding and Billing Guidelines
• A54689            MolDX: Myriad’s BRACAnalysis CDx™ Coding and Billing Guidelines
• A53585            MolDX: NSD1 Gene Tests Coding and Billing Guidelines
• A55198            MolDX: NSD1 Gene Tests Coding and Billing Guidelines
• L37915             MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
• A55200            MolDX: PIK3CA Gene Tests Coding and Billing Guidelines
• A53587            MolDX: RPS19 Gene Tests Coding and Billing Guidelines
• A54299            MolDX: RPS19 Gene Tests Coding and Billing Guidelines
• A55205            MolDX: RPS19 Gene Tests Coding and Billing Guidelines
• A53702            MolDX: SEPT9 Gene Test Coding and Billing Guidelines
• A55206            MolDX: SEPT9 Gene Test Coding and Billing Guidelines
• A53624            MolDX: SMPD1 Genetic Testing Coding and Billing Guidelines
• A54285            MolDX: SMPD1 Genetic Testing Coding and Billing Guidelines
• A55208            MolDX: SMPD1 Genetic Testing Coding and Billing Guidelines
• A55209            MolDX: STAT3 Gene Testing Coding and Billing Guidelines
• A55221            MolDX: TP53 Gene Test Coding and Billing Guidelines
• A55222            MolDX: UGT1A1 Gene Analysis Coding and Billing Guidelines
• L35000             Molecular Pathology Procedures
• A56199            Molecular Pathology Procedures- Related to Molecular Policy Procedures LCD (L35000)
• L35222             Nerve Blocks for Peripheral Neuropathy
• A56198            New Local Coverage Determination (LCD) Request Process
• L34555             Non-Covered Category III CPT Codes
• L33619             Nonvascular Extremity Ultrasound
• A55640            Not Otherwise Classified Chemotherapy Agents (NOC) Billing and Coding Guidelines
• L33567             Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
• A54068            Outpatient Cardiac Rehabilitation
• A54070            Outpatient Cardiac Rehabilitation
• A53064            Outpatient Occupational Therapy Supplemental Instructions Article
• L33631             Outpatient Physical and Occupational Therapy Services
• L34353             Outpatient Psychiatry and Psychology Services
• A52403            Outpatient Psychiatry and Psychology Services – Supplemental Instructions Article
• L34429             Outpatient Speech Language Pathology
• L37633             Partial Hospitalization Programs
• L33623             Percutaneous Coronary Intervention
• L34328             Peripheral Nerve Stimulation
• L37360             Peripheral Nerve Stimulation
• L36593             Polysomnography
• L33626             Psychiatric Partial Hospitalization Programs
• L34196             Psychiatric Partial Hospitalization Programs
• A52413            Psychiatric Partial Hospitalization Programs – Supplemental Instructions Article
• L33632             Psychiatry and Psychology Services
• L34646             Psychological and Neuropsychological Testing
• A54602            Removal of Benign Skin Lesions
• A56235            Response to Comments: Frequency of Hemodialysis
• A56233            Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs) (DL37766)
• A56234            Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) (DL37915)
• A52452            Rituximab (Rituxan®) and Rituximab and hyaluronidase human (Rituxan Hycela™) – Related to LCD L33394
• L33636             Routine Foot Care and Debridement of Nails
• L33957             Sacroiliac Joint Injection
• A56250            Sacroiliac joint injection revision to the Part B LCD
• A53021            Self-Administered Drug Exclusion List – Medical Policy Article
• A53022            Self-Administered Drug Exclusion List – Medical Policy Article
• A52800            Self-Administered Drug Exclusion List (SAD List)
• A54831            Single Chamber and Dual Chamber Permanent Cardiac Pacemakers – Coding and Billing
• L33580             Speech-Language Pathology
• L34046             Speech-Language Pathology
• A52866            Speech-Language Pathology – Supplemental Instructions Article
• L37632             Spinal Cord Stimulators for Chronic Pain
• A53018            Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based – Medical Policy Article
• L36831             Visual Electrophysiology Testing
• L37015             Visual Electrophysiology Testing
• L37808             Water Vapor Thermal Therapy for LUTS/BPH
• L36690             Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.